| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |